Showing results (21-30 of 1,983) with videos related to
Sort By:
Pageof 199
The International Journal of Biological Markers|May 9, 2015
Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCsYing Fan, Xiaoyan Ding, Jiayu Wang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 8, 2015
[Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes]Tongtong Zhang, Qing Li, Binghe Xu, et al.Breast (Edinburgh, Scotland)|May 26, 2012
Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasisXiaoyan Ding, Ying Fan, Fei Ma, et al.Plos One|April 5, 2013
There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han populationFei Ma, Ping Zhang, Dongxin Lin, et al.The International Journal of Biological Markers|December 17, 2013
Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancerHuihui Li, Fei Ma, Haijuan Wang, et al.BMC Cancer|August 29, 2023
CDK4/6 inhibitors, PI3K/mTOR inhibitors, and HDAC inhibitors as second-line treatments for hormone receptor-positive, HER2-negative advanced breast cancer: a network meta-analysisDanyang Ji, Yang Luo, Jiayu Wang, et al.Plos One|August 20, 2014
Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxelQian Li, Mei Liu, Fei Ma, et al.Zhonghua Yi Xue Za Zhi|April 16, 2014
[Patterns of liver metastasis and treatment outcomes of Chinese patients with hormonal receptor positive breast cancer]Jian Yue, Fei Ma, Lingxiao Zhang, et al.Endocrine Journal|May 3, 2011
Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancerShuyang Yao, Binghe Xu, Qing Li, et al.Journal of Oncology|December 31, 2020
Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database AnalysisJingyi Zhang, Wenna Wang, Jiayu Wang, et al.Pageof 199